Literature DB >> 1894358

Suppression by Trypanosoma brucei rhodesiense of the capacities of human T lymphocytes to express interleukin-2 receptors and proliferate after mitogenic stimulation.

F Kierszenbaum1, S Muthukkumar, L A Beltz, M B Sztein.   

Abstract

We studied the suppressive effects induced in phytohemagglutinin (PHA)-stimulated human peripheral blood mononuclear cells (PBMC) by purified blood forms of Trypanosoma brucei rhodesiense. The parasite was found to markedly impair lymphocyte proliferation (measured in terms of [3H]thymidine incorporation). The extent of this effect increased with parasite concentration and was not due to mitogen absorption, depletion of medium nutrients, or PBMC killing by the parasite. Significant reductions in interleukin-2 receptor (IL-2R) expression, determined by flow cytometric analysis, were also observed in PHA-stimulated PBMC cultured in the presence of T. b. rhodesiense as evidenced by marked decreases in the surface density of the receptor. Concomitant decreases in the percentage of IL-2R+ cells were recorded in approximately half of the experiments. A discrete, dimly stained subpopulation of IL-2R+ cells were consistently demonstrable whether or not a reduction in the percentage of IL-2R+ cells occurred. Living, but not glutaraldehyde-fixed, parasites suppressed IL-2R expression. In kinetic studies, a low but reproducible level of suppression of IL-2R was demonstrable as early as 6 h after PHA stimulation; the extent of this effect became considerably more pronounced as additional culture time elapsed. Levels of IL-2 biological activity in cocultures of T. b. rhodesiense with PHA-stimulated PBMC were comparable with or higher than those present in control cultures lacking the parasite. Therefore, insufficient levels of this cytokine would be an unlikely explanation for the noted suppression of IL-2R expression and lymphoproliferation. These effects of T. b. rhodesiense could represent an important component of the mechanism by which immunosuppression develops in African sleeping sickness.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1894358      PMCID: PMC258915          DOI: 10.1128/iai.59.10.3518-3522.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  Experimental Trypanosoma brucei infections selectively suppress both interleukin 2 production and interleukin 2 receptor expression.

Authors:  M Sileghem; R Hamers; P De Baetselier
Journal:  Eur J Immunol       Date:  1987-10       Impact factor: 5.532

2.  Decreased human IL-2 receptor expression due to a protozoan pathogen.

Authors:  F Kierszenbaum; M B Sztein; L A Beltz
Journal:  Immunol Today       Date:  1989-04

3.  Interleukin 2 regulates its own receptors.

Authors:  K A Smith; D A Cantrell
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

4.  Different mechanisms account for the suppression of interleukin 2 production and the suppression of interleukin 2 receptor expression in Trypanosoma brucei-infected mice.

Authors:  M Sileghem; A Darji; L Remels; R Hamers; P De Baetselier
Journal:  Eur J Immunol       Date:  1989-01       Impact factor: 5.532

5.  Depletion of CD8+ T cells suppresses growth of Trypanosoma brucei brucei and interferon-gamma) production in infected rats.

Authors:  M Bakhiet; T Olsson; P van der Meide; K Kristensson
Journal:  Clin Exp Immunol       Date:  1990-08       Impact factor: 4.330

6.  Selective suppressive effects of Trypanosoma cruzi on activated human lymphocytes.

Authors:  L A Beltz; F Kierszenbaum; M B Sztein
Journal:  Infect Immun       Date:  1989-08       Impact factor: 3.441

7.  Lymphocyte function in experimental African trypanosomiasis. VII. Loss of antigen-nonspecific suppressor-T-cell activity.

Authors:  R C Sizemore; J M Mansfield
Journal:  Cell Immunol       Date:  1984-09       Impact factor: 4.868

8.  Production of interferons during experimental African trypanosomiasis.

Authors:  G J Bancroft; C J Sutton; A G Morris; B A Askonas
Journal:  Clin Exp Immunol       Date:  1983-04       Impact factor: 4.330

9.  Thymosin alpha 1 modulates the expression of high affinity interleukin-2 receptors on normal human lymphocytes.

Authors:  K D Leichtling; S A Serrate; M B Sztein
Journal:  Int J Immunopharmacol       Date:  1990

10.  Trypanosoma cruzi reduces the number of high-affinity IL-2 receptors on activated human lymphocytes by suppressing the expression of the p55 and p70 receptor components.

Authors:  F Kierszenbaum; W R Cuna; L A Beltz; M B Sztein
Journal:  J Immunol       Date:  1989-07-01       Impact factor: 5.422

View more
  3 in total

1.  Depressed T-cell proliferation associated with susceptibility to experimental Taenia crassiceps infection.

Authors:  E Sciutto; G Fragoso; M Baca; V De la Cruz; L Lemus; E Lamoyi
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

2.  Suppression by Trypanosoma cruzi of T-cell receptor expression by activated human lymphocytes.

Authors:  M B Sztein; F Kierszenbaum
Journal:  Immunology       Date:  1992-10       Impact factor: 7.397

3.  Low-dose intradermal infection with trypanosoma congolense leads to expansion of regulatory T cells and enhanced susceptibility to reinfection.

Authors:  Chukwunonso Onyilagha; Ifeoma Okwor; Shiby Kuriakose; Rani Singh; Jude Uzonna
Journal:  Infect Immun       Date:  2013-12-16       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.